Home / GTBP : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does GTBP make money? Does GTBP have pricing power? What's the Earnings Whisper? Will GTBP profit more as the business scales? What is GTBP's management track record? Is GTBP's current price justified?

GT Biopharma, Inc.

$8.61 -$11.82 (-57.86%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$6.18

Day Range

$6.59$8.82

Year Range

$4.91$34.25

Market Cap

10.87M

AVG Volume

55.82K

Trailing/Forward PE

-0.08/-

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

NASDAQ

Revenue (USD)

GTBP Revenue (USD) by year
Period	Revenue (USD)
2025	0
2024	0
2023	0
2022	0
2021	0
2020	0
2019	0
2018	0
2017	0
2016	0

Net Income (USD)

GTBP Net Income (USD) by year
Period	Net Income (USD)
2025	-45.68M
2024	-13.16M
2023	-7.6M
2022	-20.88M
2021	-58.01M
2020	-36.94M
2019	-38.65M
2018	-259.19M
2017	-144.54M
2016	9.77M

Operating Income (USD)

GTBP Operating Income (USD) by year
Period	Operating Income (USD)
2025	-12.42M
2024	-14.36M
2023	-13.58M
2022	-21.26M
2021	-57.52M
2020	-6.76M
2019	-16.06M
2018	-250.07M
2017	-135.57M
2016	-9.37M

EBITDA (USD)

GTBP EBITDA (USD) by year
Period	EBITDA (USD)
2025	-44.05M
2024	-10.07M
2023	-7.38M
2022	-20.88M
2021	-57.3M
2020	-30.71M
2019	-36.51M
2018	-250.06M
2017	-135.57M
2016	-3.91M

Cash Flows (USD)

GTBP Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-12.91M
2024	-12.9M
2023	-8.85M
2022	-15.22M
2021	-15.61M
2020	-7.26M
2019	-3.66M
2018	-10.71M
2017	-5.43M
2016	-1.93M

EPS (USD)

GTBP EPS (USD) by year
Period	EPS (USD)
2025	-120.25
2024	-7.33
2023	-5.62
2022	-13.37
2021	-66.54
2020	-6.45
2019	-262.87
2018	-2592.19
2017	-12988.74
2016	93292.21

Expenses (USD)

GTBP Expenses (USD) by year
Period	Expenses (USD)
2025	12.42M
2024	14.36M
2023	13.58M
2022	21.26M
2021	57.52M
2020	6.76M
2019	11.46M
2018	21.59M
2017	135.57M
2016	9.37M

Cash & Debt (USD)

GTBP Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	6.81M
2024	3.95M
2023	13.97M
2022	16.51M
2021	31.98M
2020	5.3M
2019	28K
2018	60K
2017	576K
2016	19K

Debt ratios

GTBP Debt ratios by year
Period	Debt ratios
2025	0.08
2024	0.04
2023	0.12
2022	0.11
2021	0.09
2020	-0.05
2019	-0.03
2018	-0.03

Margins

GTBP Margins by year
Period	Margins
2015	83.33%

Return on Capital

GTBP Return on Capital by year
Period	Return on Capital
2025	-789.3%
2024	788.14%
2023	-101.62%
2022	-177.98%
2021	-264.78%
2020	125.5%
2019	200.14%
2018	-2279.56%
2017	-57.43%
2016	-51.62%

Shares Outstanding

GTBP Shares Outstanding by year
Period	Shares Outstanding
2025	220.53K
2024	1.9M
2023	1.38M
2022	1.18M
2021	8.65M
2020	16.24M
2019	4.02M
2018	2.98M
2017	2.95M
2016	11.28K

Book Value Per Share (USD)

GTBP Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	26.24
2024	-0.88
2023	5.41
2022	9.92
2021	2.53
2020	-1.81
2019	-4.81
2018	3.82
2017	85.38
2016	-1677.06

Total Assets (USD)

GTBP Total Assets (USD) by year
Period	Total Assets (USD)
2025	8.11M
2024	4.23M
2023	14.11M
2022	16.74M
2021	32.17M
2020	5.66M
2019	396K
2018	25.4M
2017	254.37M
2016	25K

Employee Count

GTBP Employee Count by year
Period	Employee Count
2025	1
2024	1
2023	2
2022	2
2021	8
2020	3
2019	2
2018	3
2017	5
2016	2

PE Ratio

GTBP PE Ratio by year
Period	PE Ratio
Apr 17	83.91
Apr 17	89.27
Apr 17	104.89
Mar 17	56.68

Free Cash Flow Yield

GTBP Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-107.9%
Sep 26	-154.07%
Aug 26	-123.87%
Aug 26	-128.67%
Aug 26	-125.54%
Aug 26	-136.01%
Jul 26	-148.24%
Jul 26	-134.16%
Jul 26	-122.25%
Jul 26	-102.36%
Jul 26	-92.21%
Jun 26	-101.22%
Jun 26	-84.67%
Jun 26	-97.32%
Jun 26	-99.73%
May 26	-90.98%
May 26	-98.92%
May 26	-110.46%
May 26	-624.3%
May 26	-682.5%
Apr 26	-749.79%
Apr 26	-617.71%
Apr 26	-634.44%
Apr 26	-520.99%
Mar 26	-572.98%
Mar 26	-509.21%
Mar 26	-565.24%
Mar 26	-499.22%
Feb 26	-603.13%
Feb 26	-626.73%
Feb 26	-621.87%
Feb 26	-535.07%
Jan 26	-436.81%
Jan 26	-404.91%
Jan 26	-386.46%
Jan 26	-425.72%
Jan 26	-352.79%
Dec 25	-346.34%
Dec 25	-380.94%
Dec 25	-436.81%
Dec 25	-472.93%
Nov 25	-364.93%
Nov 25	-392.78%
Nov 25	-313.09%
Nov 25	-606.79%
Oct 25	-599.44%
Oct 25	-549.34%
Oct 25	-543.62%
Oct 25	-552.89%
Oct 25	-588.92%
Sep 25	-489.54%
Sep 25	-480.78%
Sep 25	-466.93%
Sep 25	-397.77%
Aug 25	-402.36%
Aug 25	-338.71%
Aug 25	-280.57%
Aug 25	-260.7%
Aug 25	-257.82%
Jul 25	-226.53%
Jul 25	-226.53%
Jul 25	-209.26%
Jul 25	-166.66%
Jun 25	-131.82%
Jun 25	-153%
Jun 25	-164.31%
Jun 25	-174.12%
May 25	-180.87%
May 25	-161.47%
May 25	-209.26%
May 25	-11.99%
May 25	-11.68%
Apr 25	-11.93%
Apr 25	-11.99%
Apr 25	-12.2%
Apr 25	-11.58%
Mar 25	-11.34%
Mar 25	-10.88%
Mar 25	-10.63%
Mar 25	-11.15%
Feb 25	-11.43%
Feb 25	-12.66%
Feb 25	-10.44%
Feb 25	-10.4%
Jan 25	-10.02%
Jan 25	-9.24%
Jan 25	-9.35%
Jan 25	-8.43%
Jan 25	-7.45%
Dec 24	-7.4%
Dec 24	-12.77%
Dec 24	-8.13%
Dec 24	-8.7%
Nov 24	-7.98%
Nov 24	-7.3%
Nov 24	-7.65%
Nov 24	-8.22%
Nov 24	-9.21%
Oct 24	-8.77%
Oct 24	-11.95%

Price to Book

GTBP Price to Book by year
Period	Price to Book
Sep 26	3.75
Sep 26	2.62
Aug 26	3.26
Aug 26	3.14
Aug 26	3.22
Aug 26	1.28
Jul 26	1.17
Jul 26	1.3
Jul 26	1.42
Jul 26	1.7
Jul 26	1.89
Jun 26	1.72
Jun 26	2.05
Jun 26	1.79
Jun 26	1.74
May 26	1.91
May 26	1.76
May 26	1.57
May 26	0.36
May 26	0.33
Apr 26	0.3
Apr 26	0.36
Apr 26	0.35
Apr 26	0.43
Mar 26	0.39
Mar 26	0.44
Mar 26	0.39
Mar 26	0.45
Feb 26	0.63
Feb 26	0.6
Feb 26	0.61
Feb 26	0.71
Jan 26	0.87
Jan 26	0.94
Jan 26	0.98
Jan 26	0.89
Jan 26	1.07
Dec 25	1.09
Dec 25	0.99
Dec 25	0.87
Dec 25	0.8
Nov 25	1.04
Nov 25	0.96
Nov 25	1.21
Nov 25	0.36
Oct 25	0.36
Oct 25	0.39
Oct 25	0.4
Oct 25	0.39
Oct 25	0.37
Sep 25	0.44
Sep 25	0.45
Sep 25	0.46
Sep 25	0.54
Aug 25	0.54
Aug 25	0.64
Aug 25	0.77
Feb 25	57
Feb 25	57.26
Jan 25	59.39
Jan 25	64.45
Jan 25	63.65
Jan 25	70.58
Jan 25	79.9
Dec 24	80.43
Dec 24	46.61
Dec 24	73.24
Dec 24	68.45
Nov 24	74.57
Nov 24	81.5
Nov 24	77.77
Nov 24	25.88
Nov 24	23.08
Oct 24	24.24
Oct 24	17.79
Oct 24	15.93
Oct 24	15.7
Sep 24	16.47
Sep 24	15.93
Sep 24	16.94
Sep 24	15.15
Aug 24	16.71
Aug 24	16.86
Aug 24	17.48
Aug 24	13.91
Aug 24	16.31
Jul 24	18
Jul 24	17.87
Jul 24	19.04
Jul 24	18.72
Jun 24	18.39
Jun 24	18.98
Jun 24	18.78
Jun 24	20.54
May 24	24.37
May 24	23.92
May 24	20.28
May 24	15.38
May 24	15.24
Apr 24	15.47

No video analysis for this stock yet. Request one from our team.

News: GTBP

seekingalpha.com · 11 Sep 2026

GT Biopharma, Inc. (GTBP) Discusses TriKE Platform, Clinical Progress, and the Case for NK Cell Immunotherapy Transcript

globenewswire.com · 11 Sep 2026

GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026

SAN FRANCISCO, CALIFORNIA, Sept. 11, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, will host a live company presentation on the development of the TriKE® platform for cancer treatment today, September 11, 2026, at 2:00 p.m. Eastern Time.

globenewswire.com · 14 Aug 2026

GT Biopharma Reports Second Quarter 2026 Financial Results

Phase 1 trial evaluating GTB-3650 TriKE ® remains ongoing, with an update anticipated in 2H 2026